The ESMO Gastrointestinal Cancers Congress 2027 focuses on advancing the treatment, diagnosis, and care of gastrointestinal cancers through innovative research and multidisciplinary collaboration.
Through groundbreaking presentations, multidisciplinary tumour boards, controversy sessions, and more, attendees will have the opportunity to delve into the latest research findings, innovative therapeutic strategies, and emerging technologies that are shaping the future of GI cancers treatment.
The programme will cover a wide spectrum of topics, including molecular prevention, diagnosis, precision therapy, and patient-centered care approaches in the treatment of GI malignancies.
Networking opportunities will abound, fostering connections among peers and facilitating the exchange of ideas and best practices.
Join us at the ESMO Gastrointestinal Cancers Congress 2027 to contribute to the global effort in improving outcomes for patients with GI cancers and to stay at the forefront of oncological advancements.
